View in EDS PDF Full Text

Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.

Saved in:
Bibliographic Details
Title: Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.
Authors: Chauvin B; Clinical Pharmacy Department, Assistance Publique Hôpitaux de Paris, Hôpital Bicêtre, Hôpitaux Universitaires Paris Sud AP/HP, 78 rue du Général Leclerc, 94270, Kremlin Bicêtre, France., Drouot S, Barrail-Tran A, Taburet AM
Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2013 Oct; Vol. 52 (10), pp. 815-31.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23703578
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chauvin+B%22">Chauvin B</searchLink>; Clinical Pharmacy Department, Assistance Publique Hôpitaux de Paris, Hôpital Bicêtre, Hôpitaux Universitaires Paris Sud AP/HP, 78 rue du Général Leclerc, 94270, Kremlin Bicêtre, France.<br /><searchLink fieldCode="AU" term="%22Drouot+S%22">Drouot S</searchLink><br /><searchLink fieldCode="AU" term="%22Barrail-Tran+A%22">Barrail-Tran A</searchLink><br /><searchLink fieldCode="AU" term="%22Taburet+AM%22">Taburet AM</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227606849%22">Clinical pharmacokinetics</searchLink> [Clin Pharmacokinet] 2013 Oct; Vol. 52 (10), pp. 815-31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+part+of+Springer+Science%2BBusiness+Media%22">Adis, part of Springer Science+Business Media </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>7606849 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1926 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203125963%22">03125963 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacokinet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23703578
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40262-013-0075-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 815
    Titles:
      – TitleFull: Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chauvin B
      – PersonEntity:
          Name:
            NameFull: Drouot S
      – PersonEntity:
          Name:
            NameFull: Barrail-Tran A
      – PersonEntity:
          Name:
            NameFull: Taburet AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2013 Oct
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1926
          Numbering:
            – Type: volume
              Value: 52
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Clinical pharmacokinetics
              Type: main
ResultId 1